This talk will describe the types of early communications with the FDA and the high level requirements for nonclinical programs supporting clinical development of 4 product types: small molecules, protein therapeutics, prophylactic vaccines and cell and gene therapies. Case studies will be provided.

Speaker: Melanie Hartsough, Independent Consultant at Hartsough Nonclinical Consulting, LLC